On June 5, 2026, five prominent diabetes and obesity researchers stood outside the main hall of the American Diabetes Association's annual scientific sessions in New Orleans, handing out printed copies of an editorial. The editorial had been published in Diabetes Care, the ADA's own flagship journal, and criticized federal cuts and proposed changes to biomedical research funding. Security escorted the five out of the meeting. One of them, Steven Kahn, was the editor-in-chief of the very journal that had published the piece.
What followed is a case study in how an organization can repeatedly worsen its own crisis, and the mechanism is worth isolating, because it recurs well beyond this one association. The ADA kept taking actions intended to contain a controversy, and each action amplified the thing it was trying to suppress. The result turned a niche journal editorial, which would ordinarily reach a small specialist audience, into a national story, twice. Understanding why is more instructive than relitigating the politics that started it.
The first amplification: the expulsion
Begin with what the editorial was, because the response is only comprehensible against how minor the original act was. A journal editorial expressing concern about research-funding policy is an utterly routine artifact of academic life. It was peer-reviewed, published in the ADA's own journal, and explicitly labeled as the views of its authors rather than the organization. Handing out reprints of it at a scientific conference is close to the most ordinary thing that can happen at such a meeting.
Removing the authors from the meeting was the decision that transformed it. An editorial that might have been read by a modest number of specialists became, the moment researchers were escorted out by security for distributing it, a video that circulated widely and a story picked up by national science and general outlets. The expulsion did not contain the editorial's message. It broadcast it, and attached to it a far more dramatic narrative, that a scientific society had its own members removed for sharing peer-reviewed work.
This is the dynamic sometimes called the Streisand effect, where the attempt to suppress information is precisely what draws attention to it. The ADA's response converted a low-visibility opinion piece into a high-visibility event, and did so in the way most damaging to itself, by making the story about suppression rather than about funding. Whatever one thinks of the underlying policy dispute, the tactical self-harm is clear: the organization manufactured the very publicity it presumably wanted to avoid.
The apology that revealed the confusion
Five days later, ADA chief executive Charles Henderson apologized in a video, naming each of the five researchers and expressing regret for the hurt caused. Around the same time, senior figures resigned, including Mark Atkinson, who stepped down as chair of the scientific sessions committee.
The apology is where the organization's underlying problem became visible. An institution that was confident it had acted correctly would have defended the removal. An institution that believed it had erred would move quickly and completely to make amends. The ADA did neither cleanly: it apologized for the removal while its handling of the aftermath suggested it had not actually resolved what it thought about the original protest. An apology paired with continued ambivalence tends to satisfy no one, because it concedes the act was wrong without embracing what being wrong requires. The resignations from within the organization's own leadership signaled that the confusion was not merely external perception but a genuine internal split about what the ADA was for.
That split is the key to the whole episode. A scientific membership society has, in effect, two identities that usually coexist quietly and occasionally collide. One is a professional and scientific community whose reason for existing is open inquiry and the free exchange of ideas among its members. The other is an institution with budgets, sponsors, and relationships, including with the federal agencies and industry partners that fund and surround diabetes research. Most of the time those identities align. When members protest federal policy at the organization's own meeting, they can pull hard against each other, and an organization that has not decided which identity governs in a conflict will lurch between them. That lurching is exactly what the sequence of ADA actions looks like.
The second amplification: blocking its own journal
The most telling moment came weeks later, and it repeated the original error with the lesson apparently unlearned. Diabetes Care, the ADA's flagship journal, prepared to publish an editorial and several first-person accounts documenting the episode. The organization delayed that publication pending its review, and the pieces instead appeared on an open-access website outside the ADA's control.
Consider the structure of that decision. The original crisis was caused by suppressing the distribution of a journal editorial. The organization's response to the fallout was to suppress the publication of journal editorials about the fallout. It reached for the identical tool that had caused the damage the first time, and produced the identical result: the blocked material became more visible by being blocked, now hosted somewhere the ADA could not moderate, and the story gained a fresh news cycle about an organization censoring its own scientists a second time. An institution that had learned from June would have understood that in the current environment, suppressing scientific commentary is the single most reliable way to amplify it. The ADA did it again anyway, which suggests the institutional instinct to control the narrative was stronger than the memory of what controlling the narrative had just cost.
The policy dispute the episode sits on top of
It is worth separating the governance story, which is fairly clear, from the policy dispute underneath it, which is genuinely contested and on which this analysis takes no side.
The editorial that started everything concerned real and significant changes to federal research funding. An Association of American Universities analysis of NIH data found a roughly two-thirds drop in grant awards during the first months of fiscal 2026, and a proposed budget-office rule would change how multiyear grants are funded and give political appointees a larger role in grant decisions. To the editorial's authors, these amount to the dismantling of American biomedical research infrastructure. To the administration and its supporters, the changes are framed as reform and realignment of federal science spending toward different priorities, part of a broader agenda for the health agencies.
Which of those characterizations is closer to right is a substantive policy question that reasonable people dispute, that depends on value judgments about the proper scale and direction of federal research funding, and that this piece does not attempt to resolve. The figures are real; their interpretation is contested. The point here is narrower and separable: whatever the merits of the funding fight, the ADA's handling of members who wanted to participate in it is a self-contained story about institutional judgment, and that story does not require picking a side in the policy argument to evaluate.
How to read it
The durable lesson is not about diabetes or even about research funding. It is about what happens when an organization with a divided mission meets a moment that forces the division into the open. The ADA is both a scientific community, which is supposed to prize open debate, and an institution with relationships to protect, which creates an instinct to manage and contain. Faced with members protesting federal policy at its own meeting, it repeatedly chose containment, and each act of containment collided with the scientific-community expectation of openness and generated a backlash larger than the thing being contained.
For any membership organization watching, the practical takeaway is that suppression is an almost uniquely counterproductive tool in a community whose members are themselves communicators with platforms, because the act of suppression becomes the story and the suppressed content travels further than it otherwise would. The ADA learned this on June 5 and appeared not to have absorbed it by mid-July, which is the part that turns a single bad decision into a pattern. An organization can survive a mistake made in a chaotic moment. What erodes trust is repeating it deliberately after having seen the consequences, and doing so with the same instrument that caused the harm the first time. The editorial the ADA did not want widely read has, by now, been read far more widely than any diabetes editorial in memory, entirely because of the effort to limit it. That outcome was not inevitable. It was chosen, twice.
Primary sources
- The Scientist for the account of five researchers escorted from the ADA's 2026 meeting for distributing a Diabetes Care editorial, the identities of Steven Kahn and Justin Ryder, and researchers' reactions describing the removal as censorship.
- STAT's June coverage for the uproar among ADA members including former president John Buse, the editorial's labeling as the authors' views rather than the ADA's, and CEO Charles Henderson's June 10 video apology naming the five expelled researchers.
- Science/AAAS for the resignations of senior ADA figures following the removal.
- STAT's July 16 report for the ADA delaying Diabetes Care's publication of an editorial and first-person accounts of the episode pending its review, and those pieces appearing instead on an open-access website.
- Conexiant for the Association of American Universities analysis of NIH RePORTER data showing a roughly two-thirds drop in grant awards in early fiscal 2026 and the description of the proposed OMB rule.